Stocks CCAP Financial statements
Financial statementsCrescent Capital BDC, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Crescent Capital BDC, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Operating expenses | 40 | 54.9 | 57.6 | 101 | 107 | 98.8 |
| Operating income | -26.7 | -44.1 | -56.8 | -100 | -107 | -98.7 |
| Interest expense | 15.5 | 19.8 | 31.9 | 58.7 | 62.8 | 57.4 |
| Pre-tax income | 50.4 | 49.9 | 59.9 | 83.8 | 90.6 | 68.6 |
| Income tax | -0.05 | 1.73 | -0.33 | 0.03 | 0.16 | 0.01 |
| Net income | 54.7 | 83.6 | 15.5 | 83.8 | 73.6 | 34.5 |
| EPS, basic | 1.80 | 1.67 | 1.93 | 2.30 | 2.40 | 1.81 |
| EPS, diluted | 1.80 | 1.67 | 1.93 | 2.30 | 2.40 | 1.81 |
| Shares, basic (weighted) | 27.7 | 28.5 | 30.9 | 35.9 | 37.1 | 37 |
| Shares, diluted (weighted) | 27.7 | 28.5 | 30.9 | 35.9 | 37.1 | 37 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 1.75 | 10.1 | 6.4 | 7.78 | 10.1 | 5.04 |
| Total assets | 1,318 | 1,303 | 1,627 | 1,656 | 1,622 | |
| Total liabilities | 666 | 690 | 885 | 916 | 916 | |
| Total debt | 631 | 654 | 845 | 876 | 874 | |
| Paid-in capital | 666 | 675 | 966 | 959 | 957 | |
| Retained earnings | -13.9 | -62.5 | -223 | -218 | -251 | |
| Shareholders' equity | 560 | 652 | 613 | 743 | 741 | 706 |
| Total equity | 560 | 652 | 613 | 743 | 741 | 706 |
| Total liabilities and equity | 1,318 | 1,303 | 1,627 | 1,656 | 1,622 | |
| Shares outstanding | 30.9 | 30.9 | 37.1 | 37.1 | 37 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | 54.7 | 83.6 | 15.5 | 83.8 | 73.6 | 34.5 |
| Change in payables | -1.62 | 1.29 | 2.01 | -2.41 | 0.26 | -0.1 |
| Cash from operations | -61.8 | -158 | 28 | 92.3 | 58.9 | 74.7 |
| Stock issued | 44.3 | 52.6 | ||||
| Share buybacks | -2.21 | -1.33 | ||||
| Dividends paid | -42.6 | -47.7 | -55.3 | -64.6 | -75.2 | -67.8 |
| Cash from financing | 63.2 | 166 | -34.4 | -85 | -43.5 | -82.5 |
| Net change in cash | 1.42 | 8.68 | -6.46 | 7.4 | 15 | -7.93 |
| Interest paid | 14.5 | 15.5 | 26.9 | 55.5 | 60.4 | 52 |
| Income taxes paid | 0.69 | 2.18 | 1.97 | 0.67 | 1.34 | 1.6 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Return on equity (ROE) | -0.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -0.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -4.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Net income growth, 1y | -53.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 30.5% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -8.8% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | -24.6% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -2.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 0.1% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 26.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 38.8% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | -4.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 4.8% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 4.7% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -2.1% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 7.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | -0.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 6.2% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 6.0% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Debt / equity | 1.41x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 57.0% | Total debt / total assets. |
| Liabilities / assets | 59.5% | Total liabilities / total assets. |
| Net debt | $907.3M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -1.65x | Operating income / interest expense. |
| Tangible book value | $656.5M | Shareholders' equity - goodwill - intangible assets. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.09 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Operating cash flow per share | $1.07 | Cash from operations / diluted weighted shares. |
| Book value per share | $17.82 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $17.82 | Tangible book value / shares outstanding. |
| Cash per share | $0.42 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $352.6M | Share price x shares outstanding. |
| Enterprise value | $1.26B | Market cap + total debt - cash - short-term investments. |
| P/B | 0.54x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.54x | Market cap / tangible book value, when positive. |
| P/OCF | 8.93x | Market cap / cash from operations, when positive. |
| Earnings yield | -0.9% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 18.5% | Dividends paid over the period / market cap. |
| Shareholder yield | 18.5% | (Dividends paid + share buybacks) / market cap. |
Was Crescent Capital BDC, Inc. profitable in fiscal 2025?
Yes. Net income was $34.5M, a net margin of -.